Article
Colorectal cancer molecular biology moves into clinical practice.
Gut - 1 Jan 2011
Pritchard Colin C, Grady William M
Abstract excerpt
The promise of personalised medicine is now a clinical reality, with colorectal cancer genetics at the forefront of this next major advance in clinical medicine. This is no more evident than in the recent advances in testing of colorectal cancers for specific molecular alterations in order to guide treatment with the monoclonal antibody therapies cetuximab and panitumumab, which target the epidermal growth factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
